The price of this share is at 218,94$, Biogen Inc, with address at 225 BINNEY STREET, CAMBRIDGE, Massachusetts, 2142, United States, is a publicly traded company and its visible heads at the moment are Alfred W. Sandrock (Executive Vice President-Research & Development), Alphonse Galdes (EVP-Pharmaceutical Operations & Technology), Mark Hernon (Chief Information Officer & Senior Vice President), Michael R. McDonnell (Chief Financial Officer & Executive Vice President), Michel Vounatsos (Chief Executive Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 216,08$ - 221,98$, with a percentage difference of 219,03$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
